SecBot SecBot
DEFM14A ·Filed Oct 21, 2026

PSNL

Personalis, Inc.
NEUTRAL
Impact 5/10
Horizonweeks Processed4d 18h ago SEC0001193125-26-427872
Notable filing: DEFM14A
Actionable Insight • Neutral

The vote is virtually assured given Merck (13%) and Tempus (12%) committed to vote in favor, leaving only ~27 million additional shares needed from other holders to reach the majority-of-outstanding-shares threshold. The key uncertainty is the Tempus stock price at closing — if TEM trades below $46.00, PSNL has a termination right but is not obligated to exercise it. Monitor TEM price action and any Tempus Cash Election decision for the final consideration mix.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+1d ⚠ clustered
PSNL ▲ +0.19% at T+1d
NEUTRAL call +0.19% · α vs SPY +0.71% · entry $15.82 → $15.85
Next anchor: T+5d tomorrow
Entry = T+0 close
Oct 21, 2026
via day close
T+1d
+0.19%
call +0.19% · α +0.71%
$15.85
settled 4d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 23d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Personalis (PSNL) filed a definitive proxy statement (DEFM14A) for its special stockholder meeting on November 30, 2026, to vote on the proposed acquisition by Tempus AI (TEM). Under the deal, each PSNL share will be exchanged for Tempus Class A common stock based on a variable exchange ratio (floor of 0.3356 if TEM ≤ $48.42, otherwise $16.25 / TEM VWAP), with Tempus having the option to pay cash for up to 50% of shares at $16.25 per share. The PSNL board unanimously recommends approval, and Merck (~13% holder) and Tempus (~12% holder) have agreed to vote in favor, providing a strong path to the required majority-of-outstanding-shares threshold.

Key Financial Metrics

Deal Type
merger

Key Facts

  • Personalis special meeting scheduled for November 30, 2026, to vote on the merger with Tempus AI.
  • Each PSNL share converts to Tempus Class A common stock at a variable exchange ratio (floor 0.3356 if TEM ≤ $48.42, otherwise $16.25 / TEM VWAP).
  • Tempus may elect to pay cash for up to 50% of PSNL shares at $16.25 per share, applied pro rata across all holders.
  • PSNL board unanimously recommends approval; Merck (~13% holder) and Tempus (~12% holder) have agreed to vote in favor via voting agreements.
  • HSR waiting period expired on October 2, 2026; CMA confirmed no further questions on August 13, 2026.
  • Termination fee of approximately $76.8 million payable by either party under specified conditions.
  • Appraisal rights available under DGCL for PSNL stockholders who do not vote in favor and comply with statutory requirements.
  • Personalis has the right to terminate if Tempus stock price falls below $46.00 per share at closing.

Financial Impact

Merger consideration valued at $16.25 per PSNL share implied when TEM > $48.42; at floor of 0.3356 TEM shares per PSNL share, implied value is $16.25 per PSNL share. Tempus may pay cash for up to 50% of shares at $16.25 each, with aggregate cash consideration up to $762.4 million at 50% election. Reverse termination fee of $76.8 million payable by Tempus if regulatory impediment under HSR Act attributable to Tempus breach.

revenuedilutiondealValuecashConsideration

Risk Factors

  • Tempus stock price volatility could result in PSNL stockholders receive less value than implied at the time of the vote.
  • If Tempus stock price falls below $46.00 per share, PSNL may terminate the merger, but the board may choose not to exercise this right.
  • Integration risks post-closing, including potential loss of key personnel and customer disruption.
  • Combined company will have substantial debt (~$1.4 billion in Tempus debt as of June 30, 2026).

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
DEFM14A Filing (Primary)0001193125-26-427872
Document: d141436ddefm14a.htm0001193125-26-427872
22 reports for PSNL
Performance horizon
71% Hit rate @ T+20 5 of 7 directional calls Went positive at some point 8 of 9 best @ T+60▲ +18.82%Jul 20, 2026
Filters
Rows
Reports for PSNL — sortable, filterable
TypeNow
Oct 21, 2026
4d ago
DEFM14A
NEUTRAL ★ 5/10
$15.82awaiting T+20—$15.81 (−0.06%)
Oct 20, 2026
5d ago
425
NEUTRAL ★ 4/10
$15.90awaiting T+20—$15.81 (−0.57%)
Oct 20, 2026
5d ago
425
NEUTRAL ★ 5/10
$15.90awaiting T+20—$15.81 (−0.57%)
Oct 20, 2026
5d ago
SC 13E-3/A
NEUTRAL ★ 4/10
$15.90awaiting T+20—$15.81 (−0.57%)
Oct 6, 2026
19d ago
425
BULLISH ★ 5/10
$16.00awaiting T+20—$15.81 (−1.19%)
Oct 6, 2026
19d ago
8-K
NEUTRAL ★ 4/10
$16.00awaiting T+20—$15.81 (−1.19%)
Oct 2, 2026
23d ago
SC 13E-3/A
BULLISH ★ 6/10
$16.40awaiting T+20—$15.81 (−3.60%)
Sep 22, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$16.35 $15.90▲ +2.75%▲ +3.44%$15.81 (+3.30%)
Aug 9, 2026
11w ago
Institutional Cluster
BULLISH ★ 6/10
$14.50 $16.60▲ +14.48%▲ +15.40%$15.81 (+9.03%)
Jul 20, 2026
13w ago
425
BULLISH ★ 7/10
$13.44 $13.91▲ +3.50%▲ +0.94%$15.81 (+17.63%)
Showing 10 of 22

US Market Status

Market Open — Closes in 5h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 21, 2026